These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1856802)

  • 1. Long acting drug combinations in rheumatoid arthritis: a formal overview.
    Boers M; Ramsden M
    J Rheumatol; 1991 Mar; 18(3):316-24. PubMed ID: 1856802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.
    Stone M; Fortin PR; Pacheco-Tena C; Inman RD
    J Rheumatol; 2003 Oct; 30(10):2112-22. PubMed ID: 14528503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials on the efficacy and toxicity of slow acting antirheumatic drugs.
    Veys EM; Mielants H
    Rev Epidemiol Sante Publique; 1984; 32(3-4):230-6. PubMed ID: 6395229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.
    Rochon PA; Gurwitz JH; Simms RW; Fortin PR; Felson DT; Minaker KL; Chalmers TC
    Arch Intern Med; 1994 Jan; 154(2):157-63. PubMed ID: 8285810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cotrimoxazole treatment for rheumatoid arthritis.
    Rozin A; Schapira D; Braun-Moscovici Y; Nahir AM
    Semin Arthritis Rheum; 2001 Oct; 31(2):133-41. PubMed ID: 11590583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis.
    Horsfall MW; Shaw JP; Highton J; Cranch PJ
    N Z Med J; 1998 Jun; 111(1067):200-3. PubMed ID: 9673632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience.
    Kahan A; Menkès CJ
    Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of combination therapy of rheumatoid arthritis.
    Paulus HE
    J Rheumatol Suppl; 1996 Mar; 44():38-42. PubMed ID: 8833050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs.
    Bellamy N; Anastassiades TP; Buchanan WW; Davis P; Lee P; McCain GA; Wells GA; Campbell J
    J Rheumatol; 1991 Dec; 18(12):1901-7. PubMed ID: 1822109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
    Bellamy N; Anastassiades TP; Buchanan WW; Davis P; Lee P; McCain GA; Wells GA; Campbell J
    J Rheumatol; 1991 Dec; 18(12):1893-900. PubMed ID: 1795329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of long-acting drugs in the treatment of rheumatoid arthritis.
    McDuffie FC
    J Med Assoc Ga; 1991 Sep; 80(9):487-93. PubMed ID: 1744528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating slow-acting antirheumatic drug therapies for rheumatoid arthritis.
    Ward JR; Williams HJ; Reading JC; Egger MJ
    Clin Rheumatol; 1983 Jun; 2(2):189-95. PubMed ID: 6678694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol development for combination therapy with disease-modifying antirheumatic drugs.
    Paulus HE
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):19-25. PubMed ID: 7904085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early developments in combination therapy.
    Scott DL; Farrow S; Yeo SI
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S8-12. PubMed ID: 10589351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.